---
provider: openai
model: gpt-5.4
cached: true
start_time: '2026-04-13T05:34:38Z'
end_time: '2026-04-13T05:34:38Z'
duration_seconds: 0
template_file: manual_curation
template_variables:
  disease_name: Pineoblastoma
  mondo_id: MONDO:0016722
  category: Cancer
citation_count: 9
---

# Pineoblastoma Deep Research

## Disease anchor

- Preferred disease-level term: `MONDO:0016722` pineoblastoma.
- Oncology-specific histopathology grounding used in the disease entry:
  `NCIT:C9344` Pineoblastoma and `NCIT:C3264` Embryonal Neoplasm.
- Disease-level modeling choice: one Pineoblastoma dismech page with flat
  subtype facets, not separate pages for every ontology subclass or molecular
  subgroup.

## Modeling notes from issue #1198

- The mechanism graph unit is the disease entry, so the file is
  `kb/disorders/Pineoblastoma.yaml`, not separate files for PB-miRNA1,
  PB-miRNA2, PB-MYC/FOXR2, or PB-RB1.
- `disease_term` is MONDO-first: `MONDO:0016722`.
- NCIT is added where schema-supported and materially useful for oncology
  specificity, especially histopathology and morphology.
- Molecular subgroup labels are modeled as flat subtype facets with
  `classification: epigenetic consensus subgroup`.
- Subtype labels provide grounding and slicing context only; they do not imply
  separate disease pages or "Not Yet Curated" badges.

## Subtype framework

- Older methylation-era nomenclature from PMID:31802236:
  `PB-A`, `PB-B`, `PB-B-like`, `PB-FOXR2`
- Updated epigenetic consensus nomenclature from PMID:41291966:
  `PB-miRNA1`, `PB-miRNA2`, `PB-MYC/FOXR2`, `PB-RB1`
- Mapping implication for curation:
  the older names should be treated as earlier cohort labels, while the current
  disease entry should foreground the 2025 consensus groups.

## Disease biology

### 1. MicroRNA-processing defective pineoblastoma

- PMID:31768671 reports that alterations affecting `DROSHA`, `DGCR8`, or
  `DICER1` occur in about two thirds of the core pineoblastoma subtypes.
- PMID:41291966 refines this into the `PB-miRNA1` and `PB-miRNA2` consensus
  groups, with characteristic microRNA-processing gene alterations and frequent
  chromosome 7 gain / chromosome 14 loss.
- PMID:39992227 connects germline `DROSHA` pathogenic variants to inherited
  pineoblastoma predisposition and places all analyzed predisposition tumors in
  the `miRNA processing-altered 1` subgroup.

### 2. Developmental mechanism of miRNA-defective disease

- PMID:40240142 provides mechanistic model-organism evidence that loss of
  `Drosha` or `Dicer1` in the developing pineal gland causes tumors with loss of
  mature microRNAs, derepression of targets, S-phase upregulation, and impaired
  pinealocyte maturation.
- The paper supports a mechanistic chain of:
  microRNA-processing loss -> mature microRNA depletion ->
  proliferation-differentiation imbalance.
- `PLAGL2` emerges there as a downstream progrowth target, but in the disease
  entry it is kept subordinate to the more established disease-level mechanism
  nodes rather than promoted to its own top-level subtype program.

### 3. RB1-associated pineoblastoma

- PMID:31768671 defines a distinct `Pin-RB` subgroup that includes trilateral
  retinoblastoma and sporadic pineal tumors with `RB1` alterations.
- PMID:41291966 incorporates this biology into the consensus `PB-RB1` subgroup
  and notes especially poor outcomes in infants.
- This justified a dedicated `RB1 Pathway Inactivation` mechanism node tagged to
  subtype `PB-RB1`, rather than splitting off a separate Pineoblastoma/RB1
  disease file.

### 4. FOXR2-associated pineoblastoma

- PMID:31802236 shows that `PB-FOXR2` tumors universally overexpress `FOXR2`.
- PMID:41291966 carries this forward as consensus `PB-MYC/FOXR2`.
- This was modeled as a distinct subtype-tagged causal program
  (`FOXR2 Oncogenic Activation`) without creating a separate disease page.

### 5. Cross-subtype oncogenic event

- PMID:41291966 reports `OTX2` gain as the most frequent recurrent alteration
  across all pineoblastoma subtypes.
- Because that event spans subtype boundaries, it belongs in the disease-level
  graph as a shared mechanism node, not as a subtype or separate disease file.

## Histopathology

- PMID:11767290 characterizes pineoblastoma as an embryonal tumor with
  photosensory differentiation, including Flexner-Wintersteiner rosettes and
  fleurettes.
- PMID:6986979 identifies Homer Wright rosettes and cerebrospinal fluid spread
  as classic pineoblastoma findings.
- Histopathology terms used in the disease entry:
  `NCIT:C9344` Pineoblastoma
  `HP:0031926` Homer Wright rosette
  `HP:0031927` Flexner-Wintersteiner rosette
  `NCIT:C35950` Fleurette Formation

## Clinical presentation

- PMID:32286280 notes that early symptoms include headache, ocular disturbance,
  ataxia, and hydrocephalus from increased intracranial pressure.
- The disease entry uses ontology-grounded phenotype terms for the best-supported
  symptoms from that source: headache, ataxia, and hydrocephalus.

## Treatment

- PMID:31802236 describes risk-adapted craniospinal irradiation and chemotherapy
  in SJMB03 and induction/consolidation/maintenance chemotherapy approaches in
  SJYC07.
- PMID:40778560 adds a modern infant/young-child treatment pattern using maximal
  safe surgery followed by cyclophosphamide/etoposide/carboplatin and then
  craniospinal or focal irradiation depending on risk context.
- The disease entry therefore focuses treatment curation on:
  maximal safe surgical resection,
  craniospinal irradiation,
  multi-agent chemotherapy.
- Preclinical lysosome-disruption therapy from PMID:32286280 is kept in research
  context rather than represented as standard treatment, because it remains
  model-based and investigational.

## References used for YAML evidence

- PMID:31768671
- PMID:31802236
- PMID:32286280
- PMID:39992227
- PMID:40240142
- PMID:40778560
- PMID:41291966
- PMID:6986979
- PMID:11767290
